Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

HOPE FOR REFRACTORY HODGKIN’S DISEASE: DOXORUBICIN AND LOMUSTINE

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    HOPE FOR REFRACTORY HODGKIN’S DISEASE: DOXORUBICIN AND LOMUSTINE. Inpharma Wkly. 111, 9 (1977). https://doi.org/10.1007/BF03289463

    Download citation

    Keywords

    • Doxorubicin
    • Complete Remission
    • Dose Reduction
    • Maintenance Therapy
    • American Medical